SCHEMBL9945033

SCHEMBL9945033

CCCNC(=O)c1cc(N)c(NC)cc1N1CCC[C@H](C)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
KDM4E B2RXH2 4/20 0.40
HTT P42858 3/20 0.40
ALDH1A1 P00352 7/20 0.38
MAPT P10636 5/20 0.38
HPGD P15428 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
TP53 P04637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KMT2A Q03164 3/20 0.37
CSF1R P07333 1/20 0.37
LMNA P02545 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
CDK8 P49336 1/20 0.36
PLAUR Q03405 2/20 0.35
MAPK1 P28482 2/20 0.35
MEN1 O00255 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944767 1.00 GAA (0.45) GAAKDM4EHTTALDH1A1MAPT
SCHEMBL9944806 0.87 ALDH1A1 (0.41) GAAKDM4EALDH1A1MAPTHPGD
SCHEMBL9945032 0.84 MAPT (0.48) GAAHTTALDH1A1MAPTHPGD
SCHEMBL9944769 0.84 MAPT (0.48) GAAHTTALDH1A1MAPTHPGD
SCHEMBL9944991 0.83 KDM4E (0.36) GAAKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL9944973 0.80 GAA (0.46) GAAKDM4EHTTALDH1A1MAPT
SCHEMBL9944990 0.80 KIF18A (0.36) GAAKDM4EALDH1A1TDP1
SCHEMBL9944847 0.78 ALDH1A1 (0.43) GAAKDM4EHTTALDH1A1MAPT
SCHEMBL9944740 0.78 RAB9A (0.41) GAAKDM4EALDH1A1MAPTHPGD
SCHEMBL9946866 0.78 PTGES (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES GAA 1609/4885KDM4E 3442/4885HTT 4506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.